Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi Label ISR Credit USD UCITS ETF EUR Hedged Acc

ISCH · FR001400SQV3 · class EUR Hedged Acc · EUR · domicile France
Bonds · Corporate USD · Broad (all maturities) · North AmericaactiveEUR-hedged share classSFDR art. 8
Comparison benchmark: Bloomberg US Corporate Total Return Value Unhedged USD
TER
0.27%+ trans. 0.02%
Fund size
13 m EUR
Tracking difference
not computable
🇮🇹 tax rate
white list not published
Replication
Physicalactive management
Income
Accumulating
Duration
6.46 yrsmedium (3–7 years)
Launch 27 Nov 2024 · costs from the KID as of 2 Sept 2026 · 814 securities held · 1 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · unofficial translation, the original prevails · 4 Aug 2026
The Fund is an actively managed UCITS. By subscribing to Amundi Label ISR Credit USD UCITS ETF, you invest in an actively managed UCITS whose objective is to obtain an exposure to fixed-rate, investment grade bonds denominated in US dollars and issued by corporates, while improving environmental, social and governance ("ESG") criteria in the process of selecting and analysing the portfolio's securities relative to the Bloomberg US Corporate Index index (the "Benchmark Indicator"). The Benchmark Indicator is the Bloomberg US Corporate Bond Index index,…

Performance since series start (in euro) — base 100

27 Nov 20248 Sept 2026 · dividends reinvested where declared by the issuer
2025202610597101
High 105 (27 Feb 2026) · low 97 (13 Jan 2025) · last 101. Past performance is not indicative of future results.

Returns in euro

1 year−1.6%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+1.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)3.97%3.97%
Max drawdown−3.10%−3.10%
Sharpe-1.03-1.03
Sortino-1.36-1.36
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · ISCH · FR001400SQV31
RebalixISCH · FR001400SQV3 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · declared by the issuer
YearFundIndexTD
2025+5.26%+5.53%−0.27%

Fixed income — as declared by the issuer

Factsheet · investment-grade share (BBB−/Baa3 and above): 97.8%
Rating breakdown (% of fund)
AAA1.0%AA6.8%A44.0%BBB46.0%Other2.2%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 814 securities · top-10 weight = 9.0%
Countries (% of fund)
United States82.0%United Kingdom6.8%Canada4.0%Spain1.5%Japan1.1%
Sectors (% of fund)
Financials38.5%Health Care11.7%Technology10.3%Consumer Discretionary8.5%Industrials7.3%

Listing venues

ESMA register (FIRDS) and official exchange lists
ISCH · Euronext Paris
+ 15 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/FR001400SQV3/FRA/FRA
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR001400SQV3/FRA/FRA/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/FR001400SQV3/FRA/FRA
The live sheet, always up to date
rebalix.com/en/etf/FR001400SQV3
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · ISCH · FR001400SQV32